The COVID-19 pandemic will have a significant impact on the Asia Pacific aesthetic injectable market in the short term. Once the market stabilizes, however, the market will show strong growth. This growth will be primarily attributed to the rising adoption of aesthetic procedures in the untapped Chinese and Indian markets. Increasing aesthetic consciousness, growing urban populations with high disposable incomes, and the overall cost effectiveness of these procedures over surgical options are going to be the major drivers in these markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables (including BTX and dermal fillers) in the Asia Pacific region across a 10-year period.


The emergence of COVID-19 is affecting the aesthetic injectable market in the short term.

How will COVID-19 affect procedure volumes?

What will be the impact on market dynamics?

What strategies can companies use to remain successful in this market?

Strategic acquisitions and partnerships help manufacturers expand their product portfolios and customer bases.

Which are the most notable M&As in this market and what competitive advantages have they provided to the companies involved?

What are the strategies adopted by companies to bolster their presence in the market?

Which domestic companies are performing well in the market, and why?

Manufacturers are differentiating their products in order to promote better end-user comfort.

What initiatives are companies undertaking to improve the patient and physician experience? 

Which products are approved for use in multiple indications?

Table of contents

  • Asia Pacific
    • Abstract
    • Executive Summary
      • COVID-19 Updates
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Geographies Covered
      • Procedures and Products Covered
    • Key Report Updates
    • COVID-19 Analysis
      • Market Impact
      • Guidance and Recommendations
      • Industry and Clinician Perspectives
      • Major Market Forecast Changes and Assumptions
      • Competitive Impact
    • Aesthetic Injectable Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Domestic Competitors
        • Mergers, Acquisitions, and Partnerships
        • Physician Training and Marketing
        • Regulatory Environment
        • Distribution and Sales Network
        • Product Improvements and Innovations
      • Market Developments
    • Botulinum Toxin Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Mergers, Acquisitions, and Partnerships
    • Dermal Filler Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Material
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Product Portfolio Management
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Raghav Tangri, MRes; Diksha Garg, MS Pharm

Raghav Tangri is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at DRG (Part of Clarivate), specializing in aesthetics device markets. Raghav has been featured in the Aesthetics Journal and has participated in several white papers on policy advocacy and analysis. Raghav also has expertise in the endoscopy device space, including the markets for gastrointestinal devices, open and laparoscopic devices, and hernia repair devices. Raghav holds a Bachelor's degree in Biotechnology from Delhi Technological University and a Master's degree in Life Sciences from Imperial College London. Follow Raghav on Twitter:@rtangri_DRG

Diksha Garg is a research associate within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in the fields of dental implants and minimally invasive spine technologies. Diksha holds a Bachelor's degree in Pharmaceutical Sciences from the Delhi Institute of Pharmaceutical Sciences and Research and a Master's degree in Medicinal Chemistry from the National Institute of Pharmaceutical Education and Research, Mohali. Follow Diksha on twitter: @Diksha_DRG


Related Reports

Aesthetic Injectables | Medtech 360 | Market Insights | Latin America

The cancellation or postponement of procedures due to the COVID-19 pandemic will have a significant negative impact on the Latin American marke...

View Details

Aesthetic Injectables | Medtech 360 | Market Insights | Europe (Supplemental)

The European aesthetic injectable market will grow rapidly through 2028, driven by increasing penetration into new patient groups, such as men and younger patients, major...

View Details

Aesthetic Injectables | Medtech 360 | Market Insights | United States

The US market for aesthetic injectables will continue to grow through 2028, driven primarily by high patient demand, including from emerging patient groups such as men and younger individuals. N...

View Details

Aesthetic Injectables | Medtech 360 | Market Insights | Europe

The European aesthetic injectables market will grow rapidly through 2028, driven by increasing penetration into new patient groups, such as men and younger patients, as well as...

View Details